Jump to content

Post-op AF

From Surgopaedia

Note that post-op atrial fibrillation and atrial flutter can be managed the same, according to UTD

Epidemiology

[edit | edit source]
  • Incidence 0.4-3% after non-cardiac surgery
  • Incidence peaks post-op day 2

Secondary precipitant

[edit | edit source]
  • Always consider missed medication
  • Infection/systemic inflammation
  • Sympathetic activation in general
  • Pain
  • Low serum magnesium/other electrolytes
  • Anaemia
  • Hypothermia
  • Hypoxia
  • Hypervolaemia
  • Acidosis
  • Acute MI
  • Acute alcohol consumption
  • Thyrotoxicosis
  • Acute pericardial disease
  • Acute PE
  • Other acute pulmonary pathology
  • Caffeine is not proven to increase risk

Classification

[edit | edit source]
  • Unstable
    • Hypotension (for which AF is suspected to be causal or contributory, and standard therapy to treat other underlying causes has failed)
    • Altered mental status
    • Ischaemia
    • Heart failure
    • Cardiogenic shock
    • Very rapid ventricular rates (accessory pathway)

Investigation/initial management

[edit | edit source]
  • ECG
  • Bloods including electrolytes, free T4, TSH
  • Troponin if clinical suspicion for ACS or ECG evidence of cardiac ischaemia, or uncertainty thereof
  • Septic screen including CXR
  • Fix reversible causes above

Drug options

[edit | edit source]
  • Amiodarone
    • Rate control and rhythm control (can be a problem if not anticoagulated)
    • Contraindications
      • Sino-atrial block
      • Severe hypotension
      • Thyroid disease
      • CCF
      • Pregnancy and breastfeeding
  • Flecainide
    • Contraindications
      • Atrial flutter
      • CCF
      • Structural heart disease
      • Recent MI
  • Beta-blockers
    • Indications
      • Preferred agents when AF is associated hyper-adrenergic states
    • Contraindications
      • Asthma/COPD
      • Uncontrolled heart failure
      • Sick sinus syndrome
      • Heart block
      • Hypotension (approx <100)
      • Severe peripheral vascular disease
      • Pregnancy and breastfeeding
  • Calcium channel blockers
    • Contraindications
      • Heart failure
      • Hypotension
      • Sick sinus syndrome
      • Heart block
      • AF with WPW
      • VT
      • Pregnancy and breastfeeding
      • Already on beta-blocker
  • Digoxin
    • Popular for long-term rate control, but slow response in acute setting (peak response at least 6 hours)
    • Mostly has a role in AF with heart failure
    • Often used in combination with beta blockers or CCBs - works synergistically
    • Doesn't tend to drop BP


Initial management

[edit | edit source]
  • Approach
    • Rate-control strategy first, unless unstable and successful ventricular rate control cannot be achieved
    • Avoid RVR and the possibility of ensuing cardiac ischaemia
    • HR target of <120 is reasonable post-op
    • Indications for rhythm control:
      • Symptomatic AF despite good rate control
      • Rate control difficult to achieve
      • Patients unlikely to have a recurrence of AF (younger, less comorbidities, small left atrium)
      • Consider when good reason to avoid anticoagulation
    • >50% with new post-op AF will convert to sinus rhythm within 24 hours
      • If this occurs, no need for further management, but should have outpatient Holter and TTE
  • For rate control
    • Metoprolol 25mg PO BD (75mg max; can start with 12.5mg BD in a stable patient sometimes, particularly if there might be chronicity to AF and you’d like to start slowly) or 5mg IV (in increments up to 15mg - not good on ward) OR
    • Amiodarone 300mg IV (up to 5mg/kg) OR
    • Digoxin 0.25mg IV every two hours, to a total dose of 1.5mg, then 0.125-0.375mg IV daily
    • Calcium channel blocker or a second agent at discretion of cardiology
  • For rhythm control (unstable patient, or other indication for rhythm control)
    • IV amiodarone 300mg (up to 5mg/kg) or diltiazem/flecainide)
    • Synchronised DCR (requires peri-procedural anticoagulation and then for 4/52 afterwards)
  • Specific situations
    • Able to give PO, stable - PO metoprolol, with consideration of digoxin in CCF, or PO amiodarone if second agent is required
      • Generally worth trying PO metoprolol first, even if absorption is considered to be borderline or questionable, as long as the patient is stable
    • Unable to give PO, stable on ward - IV digoxin
    • Able to give PO, unstable - IV amiodarone and ICU
    • Unable to give PO, unstable - IV amiodarone and ICU

Subsequent management

[edit | edit source]
  • Approach
    • Re-evaluate rate control vs rhythm control
      • Rhythm - amiodarone 200mg BD for one month, then 200mg daily
      • Rate - metoprolol 25mg BD, or amiodarone same dose as above
  • Anticoagulation
    • If already on it, restart when safe
    • Single episode AF lasting <48 hours: no anticoagulation unless other high-risk features
    • Multiple episodes of AF or a single episode lasting >48 hours: anticoagulation for four weeks if CHA2DS2-VASc = 2 or more
    • Reassess after four weeks and continue anticoagulation if there are recurrences after four weeks
  • Telemetry
    • Definitely needed
      • Significant bradycardia <40bpm or pauses
      • Use of a second agent
    • Ideal but not mandatory
      • Syncope
      • Unexplained collapse
      • Non-sustained ventricular arrhythmias
    • Other patients do not need telemetry, according to Austin protocol
  • CCU
    • Ischaemic chest pain
    • Significant elevation in troponin
  • TTE
  • Cardiology F/U